Epinastine
Clinical data | |
---|---|
Trade names | Alesion, Elestat, Purivist, Relestat |
AHFS/Drugs.com | Monograph |
MedlinePlus | a604011 |
Pregnancy category |
|
Routes of administration | Eye drops |
ATC code | R06AX24 (WHO) S01GX10 (WHO) |
Pharmacokinetic data | |
Protein binding | 64% |
Biological half-life | 12 hours |
Identifiers | |
| |
CAS Number | 80012-43-7 |
PubChem (CID) | 3241 |
IUPHAR/BPS | 7176 |
DrugBank | DB00751 |
ChemSpider | 3128 |
UNII | Q13WX941EF |
KEGG | D07900 |
ChEBI | CHEBI:51032 |
ChEMBL | CHEMBL1106 |
ECHA InfoCard | 100.120.187 |
Chemical and physical data | |
Formula | C16H15N3 |
Molar mass | 249.311 g/mol |
3D model (Jmol) | Interactive image |
| |
| |
(verify) |
Epinastine (brand names Alesion, Elestat, Purivist, Relestat) is a second-generation antihistamine and mast cell stabilizer that is used in eye drops to treat allergic conjunctivitis. It is produced by Allergan and marketed by Inspire in the United States.[1] It is highly selective for the H1 receptor and does not cross the blood-brain-barrier.[2]
References
- ↑ Pradhan, S; Abhishek, K; Mah, F (2009). "Epinastine: topical ophthalmic second generation antihistamine without significant systemic side effects". Expert opinion on drug metabolism & toxicology. 5 (9): 1135–40. doi:10.1517/17425250903117284. PMID 19630694.
- ↑ Walther G, Daniel H, Bechtel WD, Brandt K (April 1990). "New tetracyclic guanidine derivatives with H1-antihistaminic properties. Chemistry of epinastine". Arzneimittel-Forschung. 40 (4): 440–6. PMID 1972625.
External links
This article is issued from Wikipedia - version of the 9/25/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.